产品简要
公司名称 :
BioLegend
其他品牌 :
Babco, Signet, Sternberger Monoclonals, Senetek, Covance
产品类型 :
抗体
产品名称 :
APC抗人类CD261(DR4, TRAIL-R1)
目录 :
307207
规格 :
25试验
价格 :
149美元
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
APC
克隆名称 :
DJR1
反应物种 :
人类
应用 :
流式细胞仪
更多信息或购买 :
BioLegend 产品网页
文章摘录数: 15
出版应用/物种/样本/稀释参考文献
  • 流式细胞仪; 人类; 图 s4d
Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed 出版商
Henjum K, Arskog V, Jendresen C, Fladby T, Torp R, Nilsson L. Analyzing microglial-associated Aβ in Alzheimer's disease transgenic mice with a novel mid-domain Aβ-antibody. Sci Rep. 2020;10:10590 pubmed 出版商
Burrus C, McKinstry S, Kim N, Ozlu M, Santoki A, Fang F, et al. Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival. Cell Rep. 2020;30:642-657.e6 pubmed 出版商
Goldblatt D, Flores J, Valverde Ha G, Jaramillo A, Tkachman S, Kirkpatrick C, et al. Inducible epithelial resistance against acute Sendai virus infection prevents chronic asthma-like lung disease in mice. Br J Pharmacol. 2020;177:2256-2273 pubmed 出版商
Phalke S, Huang Y, Rubtsova K, Getahun A, Sun D, Reinhardt R, et al. γδ T cells shape memory-phenotype αβ T cell populations in non-immunized mice. PLoS ONE. 2019;14:e0218827 pubmed 出版商
Zhu Z, Liu J, Yang C, Li M, Wu R, Xiong Z. Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells. Cell Death Dis. 2019;10:118 pubmed 出版商
Brin E, Wu K, Dagostino E, Meng Chiang Kuo M, He Y, Shia W, et al. TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase. Oncotarget. 2018;9:36914-36928 pubmed 出版商
Cordeau M, Belounis A, Lelaidier M, Cordeiro P, Sartelet H, Herblot S, et al. Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells. PLoS ONE. 2016;11:e0164401 pubmed 出版商
Burger J, Landau D, Taylor Weiner A, Bozic I, Zhang H, Sarosiek K, et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat Commun. 2016;7:11589 pubmed 出版商
Chandrasekaran S, Marshall J, Messing J, Hsu J, King M. TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids. PLoS ONE. 2014;9:e111487 pubmed 出版商
Choi Y, Lee J, Lee H, Chang D, Sung P, Jung M, et al. Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis. Gut. 2015;64:1303-13 pubmed 出版商
Sonnemann J, Trommer N, Becker S, Wittig S, Grauel D, Palani C, et al. Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation. Cancer Biol Ther. 2012;13:417-24 pubmed 出版商
Malin D, Chen F, Schiller C, Koblinski J, Cryns V. Enhanced metastasis suppression by targeting TRAIL receptor 2 in a murine model of triple-negative breast cancer. Clin Cancer Res. 2011;17:5005-15 pubmed 出版商
Chen K, Chen H, Tai W, Feng W, Hsu C, Chen P, et al. Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharmacol Exp Ther. 2011;337:155-61 pubmed 出版商
Lundqvist A, Abrams S, Schrump D, Alvarez G, Suffredini D, Berg M, et al. Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity. Cancer Res. 2006;66:7317-25 pubmed
产品信息
抗原 :
CD261
Apps. Abbrev. :
流式细胞仪
目录 :
307207
克隆 :
DJR1
产品 :
APC抗人类CD261(DR4, TRAIL-R1)
抗体亚型 :
Mouse IgG1, κ
其他名称 :
TRAIL-R1, ApoE基因2, CD261, TNFRSF10A
规格 :
25试验
价格(美元) :
149美元
反应物种 :
人类
克隆性 :
单克隆
宿主 :
小鼠
共轭标签/标签/标记 :
APC
免疫原 :
Extracellular domain of DR4-human IgG1 Fc fusion protein
应用注释 :
Additional reported applications (for the relevant formats) include: The DJR1 antibody is useful for immunofluorescent staining and flow cytometric analysis of DR4/TRAIL-R1 receptor expression. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 307206) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated antibody or biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by SAv-PE (Cat. No. 405204)).
更多信息或购买 :
BioLegend 产品网页
公司信息
BioLegend
8999 BioLegend Way
San Diego, CA 92121
customerserv@biolegend.com
https://www.biolegend.com
1-858-455-9588
公司总部: 美国
Biolegend公司为生物医学研究提供顶级的抗体及试剂产品，旨在加速生命科学领域的研发工作。